European shares rise as Genmab jumps
European shares advanced on Tuesday as healthcare stocks gained following positive trial results from Genmab. Meanwhile, euro zone bond yields eased after recent rallies driven by fiscal and inflation concerns.
Xurve View
Insights:
Xurve View
European shares rose 0.8% to 638.67 points during Tuesday morning trading, driven by healthcare gains. The STOXX 600 index headed toward a one-week high. This advance follows a retreat in euro zone bond yields from recent multi-decade peaks.
